Yale Lawmetadata only
Tigit And Gdf-15 As Biomarkers And Targets In Renal Cell Carcinoma Resistant To Immune Checkpoint Inhibitors
biomarker, gdf-15, immunotherapy, pd-1, rcc, tigit, medicine and health sciences
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 260915
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.